{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:42:04Z","timestamp":1791895324915,"version":"4.3.4"},"reference-count":163,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.pnpbp.2012.06.001","type":"journal-article","created":{"date-parts":[[2012,6,10]],"date-time":"2012-06-10T11:42:37Z","timestamp":1339328557000},"page":"263-272","source":"Crossref","is-referenced-by-count":110,"title":["Developments in harmine pharmacology \u2014 Implications for ayahuasca use and drug-dependence treatment"],"prefix":"10.1016","volume":"39","author":[{"given":"Daniel I.","family":"Brierley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.abb.2010.12.024","article-title":"Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)","volume":"507","author":"Adayev","year":"2010","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/00952990.2011.644002","article-title":"The efficacy of mirtazapine in the treatment of cocaine dependence with comorbid depression","volume":"38","author":"Afshar","year":"2012","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0830","first-page":"CD006306","article-title":"Antipsychotic medications for cocaine dependence","volume":"3","author":"Amato","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.pnpbp.2012.06.001_bb0020","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/j.1471-4159.2006.03662.x","article-title":"Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient mice","volume":"96","author":"Anderson","year":"2006","journal-title":"J Neurochem"},{"issue":"18","key":"10.1016\/j.pnpbp.2012.06.001_bb0025","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/S0024-3205(03)00647-7","article-title":"Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats","volume":"73","author":"Aricioglu-Kartal","year":"2003","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070797","article-title":"The selectivity of protein kinase inhibitors: a further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/02791072.2009.10400530","article-title":"A six-month prospective evaluation of personality traits. Psychiatric symptoms and quality of life in ayahuasca-naive subjects","volume":"41","author":"Barbosa","year":"2009","journal-title":"J Psychoactive Drugs"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0040","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1742-4658.2010.07956.x","article-title":"Activation, regulation, and inhibition of DYRK1A","volume":"278","author":"Becker","year":"2011","journal-title":"FEBS J"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0301-0082(94)90081-7","article-title":"The functional role of monoamine oxidases A and B in the mammalian central nervous system","volume":"42","author":"Berry","year":"1994","journal-title":"Prog Neurobiol"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2012.06.001_bb0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejphar.2006.09.021","article-title":"The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes","volume":"552","author":"Bour","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.06.001_bb0835","series-title":"Proceedings of the British Pharmacological Society","article-title":"Effect of harmine on electrically evoked dopamine efflux in the rat nucleus accumbens core and shell brain slice","author":"Brierley","year":"2011"},{"key":"10.1016\/j.pnpbp.2012.06.001_bb0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0079-6123(08)00916-3","article-title":"Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse","volume":"172","author":"Bubar","year":"2008","journal-title":"Prog Brain Res"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0840","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/02791072.2008.10400630","article-title":"The \u201cvine of the soul\u201d vs. the controlled substances act: implications of the hoasca case","volume":"40","author":"Bullis","year":"2008","journal-title":"J Psychoactive Drugs"},{"issue":"6","key":"10.1016\/j.pnpbp.2012.06.001_bb0070","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/mol.60.6.1181","article-title":"Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor","volume":"60","author":"Bunzow","year":"2001","journal-title":"Mol Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2012.06.001_bb0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugalcdep.2010.03.015","article-title":"Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users","volume":"111","author":"Cakic","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/02791072.2005.10399797","article-title":"Fast and slow metabolizers of hoasca","volume":"37","author":"Callaway","year":"2005","journal-title":"J Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.pnpbp.2012.06.001_bb0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/02791072.1998.10399712","article-title":"Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions","volume":"30","author":"Callaway","year":"1998","journal-title":"J Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0378-8741(98)00168-8","article-title":"Pharmacokinetics of hoasca alkaloids in healthy humans","volume":"65","author":"Callaway","year":"1999","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"10.1016\/j.pnpbp.2012.06.001_bb0845","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/jat\/30.6.406","article-title":"A demand for clarity regarding a case report on the ingestion of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in an ayahuasca preparation","volume":"30","author":"Callaway","year":"2006","journal-title":"J Anal Toxicol"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2012.06.001_bb0100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuropharm.2008.06.075","article-title":"Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis","volume":"56","author":"Carlezon","year":"2009","journal-title":"Neuropharmacology"},{"issue":"20","key":"10.1016\/j.pnpbp.2012.06.001_bb0105","doi-asserted-by":"crossref","first-page":"17597","DOI":"10.1074\/jbc.M111101200","article-title":"Dynamin is a minibrain kinase\/dual specificity Yak1-related kinase 1A substrate","volume":"277","author":"Chen-Hwang","year":"2002","journal-title":"J Biol Chem"},{"issue":"6927","key":"10.1016\/j.pnpbp.2012.06.001_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature01451","article-title":"Regulated portals of entry into the cell","volume":"422","author":"Conner","year":"2003","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.pnpbp.2012.06.001_bb0115","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/npp.2010.119","article-title":"The serotonin 5-ht2c receptor in medial prefrontal cortex exerts rheostatic control over the motivational salience of cocaine-associated cues: new observations from preclinical animal research","volume":"35","author":"Cunningham","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0120","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.neuropharm.2011.04.034","article-title":"Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues","volume":"61","author":"Cunningham","year":"2011","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.pnpbp.2012.06.001_bb0125","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.bmcl.2012.01.028","article-title":"Structure\u2013activity relationship study of beta-carboline derivatives as haspin kinase inhibitors","volume":"22","author":"Cuny","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.npp.1300600","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"30","author":"Dackis","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2012.06.001_bb0135","doi-asserted-by":"crossref","unstructured":"Dackis CA, Kampman KM, Lynch KG, Plebani JG, Pettinati HM, Sparkman T, et al. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. J Subst Abuse Treat in press. http:\/\/dx.doi.org\/10.1016\/j.jsat.2011.12.014.","DOI":"10.1016\/j.jsat.2011.12.014"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2012.06.001_bb0140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-2999(02)02390-7","article-title":"5-HT2 receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization","volume":"453","author":"Davidson","year":"2002","journal-title":"Eur J Pharmacol"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2012.06.001_bb0850","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00213-004-2010-8","article-title":"Risperidone diminishes cocaine-induced craving","volume":"178","author":"De La Garza","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"10.1016\/j.pnpbp.2012.06.001_bb0150","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.4088\/JCP.08r04856blu","article-title":"Interactions between tamoxifen and antidepressants via cytochrome P450 2D6","volume":"70","author":"Desmarais","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/02791072.2005.10399794","article-title":"Report on psychoactive drug use among adolescents using ayahuasca within a religious Context","volume":"37","author":"Doering-Silveira","year":"2005","journal-title":"J Psychoactive Drugs"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0006-8993(90)90318-6","article-title":"Dopamine uptake inhibitory capacities of beta-carboline and 3,4-dihydro-beta-carboline analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation products","volume":"509","author":"Drucker","year":"1990","journal-title":"Brain Res"},{"issue":"9","key":"10.1016\/j.pnpbp.2012.06.001_bb0165","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0165-6147(98)01244-9","article-title":"\u2018Seeing through a glass darkly\u2019: casting light on imidazoline \u2018I\u2019 sites","volume":"19","author":"Eglen","year":"1998","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0170","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drugalcdep.2006.04.010","article-title":"Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence","volume":"85","author":"Elkashef","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0175","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugalcdep.2010.03.024","article-title":"Assessment of addiction severity among ritual users of ayahuasca","volume":"111","author":"Fabregas","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.pnpbp.2012.06.001_bb0180","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4088\/PCC.v07n0602","article-title":"Atypicality of atypical antipsychotics","volume":"7","author":"Farah","year":"2005","journal-title":"Prim. Care Companion J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2012.06.001_bb0190","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.euroneuro.2005.08.005","article-title":"Antidepressant-like effect of harmane and other beta-carbolines in the mouse forced swim test","volume":"16","author":"Farzin","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0185","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.pbb.2011.01.001","article-title":"Effects of harmane and other beta-carbolines on apomorphine-induced licking behavior in rat","volume":"98","author":"Farzin","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"10.1016\/j.pnpbp.2012.06.001_bb0200","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00213-005-0197-y","article-title":"Contribution of serotonin (5-HT) 5-HT2 receptor subtypes to the discriminative stimulus effects of cocaine in rats","volume":"183","author":"Filip","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0205","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.neuropharm.2011.02.025","article-title":"Impulsive action induced by amphetamine, cocaine and MK801 is reduced by 5-HT(2C) receptor stimulation and 5-HT(2A) receptor blockade","volume":"61","author":"Fletcher","year":"2011","journal-title":"Neuropharmacology"},{"issue":"5916","key":"10.1016\/j.pnpbp.2012.06.001_bb0210","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.1166127","article-title":"The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator","volume":"323","author":"Fontanilla","year":"2009","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.pnpbp.2012.06.001_bb0225","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.pnpbp.2009.07.021","article-title":"Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus","volume":"33","author":"Fortunato","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2012.06.001_bb0215","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00702-010-0451-2","article-title":"Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus","volume":"117","author":"Fortunato","year":"2010","journal-title":"J Neural Transm"},{"issue":"4\u20135","key":"10.1016\/j.pnpbp.2012.06.001_bb0220","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.brainresbull.2009.09.008","article-title":"Effects of beta-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties","volume":"81","author":"Fortunato","year":"2010","journal-title":"Brain Res Bull"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0230","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0376-8716(98)00154-9","article-title":"Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture","volume":"54","author":"Freedland","year":"1999","journal-title":"Drug Alcohol Depend"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2012.06.001_bb0235","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.forsciint.2008.05.003","article-title":"A case of beta-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract","volume":"179","author":"Frison","year":"2008","journal-title":"Forensic Sci Int"},{"issue":"5","key":"10.1016\/j.pnpbp.2012.06.001_bb0240","doi-asserted-by":"crossref","first-page":"e19264","DOI":"10.1371\/journal.pone.0019264","article-title":"Beta-carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sites","volume":"6","author":"Frost","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0245","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1360-0443.2006.01652.x","article-title":"Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids","volume":"102","author":"Gable","year":"2007","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.pnpbp.2012.06.001_bb0250","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0028-3908(90)90136-F","article-title":"Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissues from the brain of the rat","volume":"29","author":"Garrett","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2012.06.001_bb0255","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jchromb.2011.11.014","article-title":"Determination of N,N-dimethyltryptamine in Mimosa tenuiflora inner barks by matrix solid-phase dispersion procedure and GC\u2013MS","volume":"881\u2013882","author":"Gaujac","year":"2012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"6 Suppl 3","key":"10.1016\/j.pnpbp.2012.06.001_bb0260","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1212\/WNL.47.6_Suppl_3.137S","article-title":"Pharmacology of selegiline","volume":"47","author":"Gerlach","year":"1996","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0265","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0376-8716(99)00148-9","article-title":"Binding of \u03b2-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors","volume":"60","author":"Glennon","year":"2000","journal-title":"Drug Alcohol Depend"},{"issue":"21","key":"10.1016\/j.pnpbp.2012.06.001_bb0270","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1111\/j.1742-4658.2009.07346.x","article-title":"Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation","volume":"276","author":"Gockler","year":"2009","journal-title":"FEBS J"},{"issue":"5","key":"10.1016\/j.pnpbp.2012.06.001_bb0280","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.npp.1300392","article-title":"Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials","volume":"29","author":"Grabowski","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0290","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0376-8716(97)00163-4","article-title":"Investigation of hallucinogenic and related \u03b2-carbolines","volume":"50","author":"Grella","year":"1998","journal-title":"Drug Alcohol Depend"},{"issue":"24","key":"10.1016\/j.pnpbp.2012.06.001_bb0285","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1016\/j.bmcl.2003.09.027","article-title":"Binding of beta-carbolines at 5-HT(2) serotonin receptors","volume":"13","author":"Grella","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0295","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00005053-199602000-00004","article-title":"Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil","volume":"184","author":"Grob","year":"1996","journal-title":"J Nerv Ment Dis"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2012.06.001_bb0300","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2003.08.064","article-title":"Rapid regulation of dopamine transporter function by substrates. Blockers and presynaptic receptor ligands","volume":"479","author":"Gulley","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.pnpbp.2012.06.001_bb0305","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11920-003-0067-4","article-title":"Hallucinogens: an update","volume":"5","author":"Halpern","year":"2003","journal-title":"Curr Psychiatry Rep"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0310","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1176\/appi.ajp.158.3.481","article-title":"Hallucinogens on the internet: a vast new source of underground drug information","volume":"158","author":"Halpern","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2012.06.001_bb0315","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.lfs.2005.09.005","article-title":"Hallucinogenic botanicals of America: a growing need for focused drug education and research","volume":"78","author":"Halpern","year":"2005","journal-title":"Life Sci"},{"issue":"8","key":"10.1016\/j.pnpbp.2012.06.001_bb0855","first-page":"SR15","article-title":"Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament","volume":"14","author":"Halpern","year":"2008","journal-title":"Med Sci Monit"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0325","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1615\/JEnvironPatholToxicolOncol.v30.i2.40","article-title":"Studies on anti-metastatic and anti-invasive effects of harmine using highly metastatic murine B16F-10 melanoma cells","volume":"30","author":"Hamsa","year":"2011","journal-title":"J Environ Pathol Toxicol Oncol"},{"issue":"8","key":"10.1016\/j.pnpbp.2012.06.001_bb0860","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/15563650.2011.615318","article-title":"Clinical toxicology of newer recreational drugs","volume":"49","author":"Hill","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0335","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-009-1524-5","article-title":"Chronic treatment with monoamine oxidase-b inhibitors decreases cocaine reward in mice","volume":"205","author":"Ho","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2012.06.001_bb0340","series-title":"Ethnopharmacologic search for psychoactive drugs","first-page":"339","article-title":"Chemical constituents and pharmacology of South American snuffs","author":"Holmstedt","year":"1967"},{"issue":"6","key":"10.1016\/j.pnpbp.2012.06.001_bb0345","first-page":"409","article-title":"Imidazoline binding sites on receptors and enzymes: emerging targets for novel antidepressant drugs?","volume":"28","author":"Holt","year":"2003","journal-title":"J Psychiatry Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2012.06.001_bb0350","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0161-813X(03)00104-9","article-title":"On the binding of monoamine oxidase inhibitors to some sites distinct from the MAO active site, and effects thereby elicited","volume":"25","author":"Holt","year":"2004","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0355","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0376-8716(01)00123-5","article-title":"Beta-carboline binding to imidazoline receptors","volume":"64","author":"Husbands","year":"2001","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0360","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s002130100879","article-title":"Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition","volume":"159","author":"Iurlo","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0365","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0376-8716(03)00009-7","article-title":"A pilot trial of olanzapine for the treatment of cocaine dependence","volume":"70","author":"Kampman","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0375","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/abbi.1996.9771","article-title":"Inhibition of monoamine oxidase A by beta-carboline derivatives","volume":"337","author":"Kim","year":"1997","journal-title":"Arch Biochem Biophys"},{"issue":"10","key":"10.1016\/j.pnpbp.2012.06.001_bb0370","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1046\/j.0953-816x.2001.01563.x","article-title":"Protective effect of harmaline and harmalol against dopamine- and 6-hydroxydopamine-induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells","volume":"13","author":"Kim","year":"2001","journal-title":"Eur J Neurosci"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0380","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000321994","article-title":"Overexpression of Dyrk1A causes the defects in synaptic vesicle endocytosis","volume":"18","author":"Kim","year":"2010","journal-title":"Neurosignals"},{"key":"10.1016\/j.pnpbp.2012.06.001_bb0865","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1196\/annals.1304.048","article-title":"Identification of an I(2) binding protein from rabbit brain","volume":"1009","author":"Kimura","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0390","first-page":"179","article-title":"(\u2212)Deprenyl (selegiline): past, present and future","volume":"8","author":"Knoll","year":"2000","journal-title":"Neurobiology (Bp)"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0395","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/sj.bjp.0702822","article-title":"Evidence for a role for central 5-HT2B as well as 5-HT2A receptors in cardiovascular regulation in anaesthetized rats","volume":"128","author":"Knowles","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0400","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugpo.2011.06.006","article-title":"Ayahuasca and the process of regulation in brazil and internationally: implications and challenges","volume":"23","author":"Labate","year":"2012","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0405","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuro.2006.05.019","article-title":"Monoamine oxidase and tobacco dependence","volume":"28","author":"Lewis","year":"2007","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0410","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainres.2006.04.071","article-title":"(\u2212)-Epigallocatechin gallate regulates dopamine transporter internalization via protein kinase C-dependent pathway","volume":"1097","author":"Li","year":"2006","journal-title":"Brain Res"},{"issue":"7\u20138","key":"10.1016\/j.pnpbp.2012.06.001_bb0415","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.neuropharm.2010.10.016","article-title":"Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression","volume":"60","author":"Li","year":"2011","journal-title":"Neuropharmacology"},{"issue":"14","key":"10.1016\/j.pnpbp.2012.06.001_bb0420","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2174\/138161209788168001","article-title":"Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today","volume":"15","author":"Lopez-Munoz","year":"2009","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0425","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1212\/01.wnl.0000172352.88359.2d","article-title":"Blood harmane concentrations and dietary protein consumption in essential tremor","volume":"65","author":"Louis","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0430","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ptr.2860","article-title":"The beta-carboline alkaloid harmine inhibits BCRP and can reverse resistance to the anticancer drugs mitoxantrone and camptothecin in breast cancer cells","volume":"24","author":"Ma","year":"2010","journal-title":"Phytother Res"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0440","first-page":"32","article-title":"Takiwasi: ayahuasca and shamanism in addiction therapy","volume":"6","author":"Mabit","year":"1996","journal-title":"MAPS Bull"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0435","first-page":"25","article-title":"Using indigenous medicinal knowledge to treat drug addiction","volume":"12","author":"Mabit","year":"2002","journal-title":"MAPS Bull"},{"key":"10.1016\/j.pnpbp.2012.06.001_bb0445","first-page":"565","article-title":"Traditional and complementary therapies in Parkinson's disease","volume":"80","author":"Manyam","year":"1999","journal-title":"Adv Neurol"},{"issue":"6","key":"10.1016\/j.pnpbp.2012.06.001_bb0450","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1601-183X.2006.00285.x","article-title":"Dopaminergic deficiency in mice with reduced levels of the dual-specificity tyrosine-phosphorylated and regulated kinase 1A, Dyrk1A(+\/\u2212)","volume":"6","author":"Martinez de Lagran","year":"2007","journal-title":"Genes Brain Behav"},{"issue":"5","key":"10.1016\/j.pnpbp.2012.06.001_bb0455","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/jnr.23007","article-title":"Effect of Dyrk1a activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice","volume":"90","author":"Mazur-Kolecka","year":"2012","journal-title":"J Neurosci Res"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0460","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/02791072.2000.10400456","article-title":"Bufotenine: toward an understanding of possible psychoactive mechanisms","volume":"32","author":"McBride","year":"2000","journal-title":"J Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0465","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/bmc.1657","article-title":"Methodology for determining major constituents of ayahuasca and their metabolites in blood","volume":"26","author":"McIlhenny","year":"2012","journal-title":"Biomed Chromatogr"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0470","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pharmthera.2004.03.002","article-title":"Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges","volume":"102","author":"McKenna","year":"2004","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0475","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0378-8741(84)90003-5","article-title":"Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca","volume":"10","author":"McKenna","year":"1984","journal-title":"J Ethnopharmacol"},{"issue":"1; 10","key":"10.1016\/j.pnpbp.2012.06.001_bb0870","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5042\/daat.2010.0123","article-title":"Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition","volume":"10","author":"Measham","year":"2010","journal-title":"Drugs Alcohol Today"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0485","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0091-3057(86)90239-X","article-title":"Harmine reverses the inhibition of lordosis by the 5-HT2 antagonists pirenperone and ketanserin in the female rat","volume":"25","author":"Mendelson","year":"1986","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"10.1016\/j.pnpbp.2012.06.001_bb0490","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000139201","article-title":"Different effects of harmine on plasma concentrations of l-DOPA and on cerebral dopamine metabolism in rabbits and rats","volume":"48","author":"Meneguz","year":"1994","journal-title":"Pharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2012.06.001_bb0495","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/02791072.1998.10399709","article-title":"Hallucinogenic drugs and plants in psychotherapy and shamanism","volume":"30","author":"Metzner","year":"1998","journal-title":"J Psychoactive Drugs"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2012.06.001_bb0500","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejphar.2005.06.023","article-title":"High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA\/noradrenaline synthesis in the brain","volume":"518","author":"Miralles","year":"2005","journal-title":"Eur J Pharmacol"},{"issue":"22","key":"10.1016\/j.pnpbp.2012.06.001_bb0505","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.lfs.2006.07.004","article-title":"Effects of beta-carboline alkaloids on the object recognition task in mice","volume":"79","author":"Moura","year":"2006","journal-title":"Life Sci"},{"issue":"39","key":"10.1016\/j.pnpbp.2012.06.001_bb0510","doi-asserted-by":"crossref","first-page":"9297","DOI":"10.1021\/bi9010557","article-title":"Dyrk1A binds to multiple endocytic proteins required for formation of clathrin-coated vesicles","volume":"48","author":"Murakami","year":"2009","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.pnpbp.2012.06.001_bb0515","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.bjp.0703142","article-title":"Harmane produces hypotension following microinjection into the RVLM: possible role of I(1)-imidazoline receptors","volume":"129","author":"Musgrave","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2012.06.001_bb0520","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0006-8993(95)00082-2","article-title":"Methyl-beta-carbolinium analogs of MPP+ cause nigrostriatal toxicity after substantia nigra injections in rats","volume":"675","author":"Neafsey","year":"1995","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.pnpbp.2012.06.001_bb0525","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.pbb.2005.11.012","article-title":"A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegiline","volume":"82","author":"Newton","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"issue":"7","key":"10.1016\/j.pnpbp.2012.06.001_bb0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms1090","article-title":"Development of a novel selective inhibitor of the down syndrome-related kinase Dyrk1A","volume":"1","author":"Ogawa","year":"2010","journal-title":"Nat Commun"},{"key":"10.1016\/j.pnpbp.2012.06.001_bb0545","series-title":"Ayahuasca analogues Pangean Entheogens","author":"Ott","year":"1994"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0540","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02791072.1999.10471741","article-title":"Pharmahuasca: human pharmacology of oral DMT plus harmine","volume":"31","author":"Ott","year":"1999","journal-title":"J Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0535","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/02791072.2001.10400574","article-title":"Pharmanopo-psychonautics: human intranasal, sublingual, intrarectal, pulmonary and oral pharmacology of bufotenine","volume":"33","author":"Ott","year":"2001","journal-title":"J Psychoactive Drugs"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0550","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.neuropharm.2006.08.010","article-title":"In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: evidence for two distinct I2 binding sites","volume":"52","author":"Paterson","year":"2007","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0555","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0169-328X(01)00013-4","article-title":"Inhibition of MAO-A fails to alter cocaine-induced increases in extracellular dopamine and norepinephrine in rat nucleus accumbens","volume":"87","author":"Pepper","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0560","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1476-5381.2009.00522.x","article-title":"Dopamine transporter down-regulation following repeated cocaine: implications for 3,4-methylenedioxymethamphetamine-induced acute effects and long-term neurotoxicity in mice","volume":"159","author":"Peraile","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0565","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(95)11469-D","article-title":"Interaction of beta-carbolines with central dopaminergic transmission in mice: structure\u2013activity relationships","volume":"189","author":"Pimpinella","year":"1995","journal-title":"Neurosci Lett"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2012.06.001_bb0570","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00213-010-2071-9","article-title":"Blockade of 5-HT2A receptors in the medial prefrontal cortex attenuates reinstatement of cue-elicited cocaine-seeking behavior in rats","volume":"213","author":"Pockros","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"issue":"46","key":"10.1016\/j.pnpbp.2012.06.001_bb0575","doi-asserted-by":"crossref","first-page":"27961","DOI":"10.1074\/jbc.270.46.27961","article-title":"Imidazoline\/guanidinium binding domains on monoamine oxidases, relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase b","volume":"270","author":"Raddatz","year":"1995","journal-title":"J Biol Chem"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2012.06.001_bb0580","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1360-0443.2005.00990.x","article-title":"A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10\/l-carnitine for the treatment of cocaine dependence","volume":"100","author":"Reid","year":"2005","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0585","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bmc.2010.11.041","article-title":"Synthesis and evaluation of beta-carboline derivatives as potential monoamine oxidase inhibitors","volume":"19","author":"Reniers","year":"2011","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"10.1016\/j.pnpbp.2012.06.001_bb0590","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4161\/oxim.3.5.13109","article-title":"Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus","volume":"3","author":"Reus","year":"2010","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0600","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s002130000606","article-title":"Subjective effects and tolerability of the South American psychoactive beverage ayahuasca in healthy volunteers","volume":"154","author":"Riba","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0605","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/jpet.103.049882","article-title":"Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics","volume":"306","author":"Riba","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"7\u20138","key":"10.1016\/j.pnpbp.2012.06.001_bb0595","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/dta.1344","article-title":"Metabolism and Disposition of N, N-Dimethyltryptamine and Harmala Alkaloids After Oral Administration of Ayahuasca","volume":"4","author":"Riba","year":"2012","journal-title":"Drug Test. Anal"},{"key":"10.1016\/j.pnpbp.2012.06.001_bb0875","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1196\/annals.1304.018","article-title":"Endogenous beta-carbolines as clonidine-displacing substances","volume":"1009","author":"Robinson","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0615","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/02791072.2008.10400645","article-title":"Reassessing the cultural and psychopharmacological significance of Banisteriopsis caapi: preparation, classification and use among the Piaroa of Southern Venezuela","volume":"40","author":"Rodd","year":"2008","journal-title":"J Psychoactive Drugs"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0620","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuint.2010.10.015","article-title":"Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex","volume":"58","author":"Rollema","year":"2011","journal-title":"Neurochem Int"},{"issue":"17","key":"10.1016\/j.pnpbp.2012.06.001_bb0625","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2174\/156802606778249775","article-title":"Dopamine transporter ligands: recent developments and therapeutic potential","volume":"6","author":"Runyon","year":"2006","journal-title":"Curr Top Med Chem"},{"issue":"4028","key":"10.1016\/j.pnpbp.2012.06.001_bb0630","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.175.4028.1365","article-title":"Psychotomimetic N-methylated tryptamines: formation in brain in vivo and in vitro","volume":"175","author":"Saavedra","year":"1972","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0635","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jep.2009.10.030","article-title":"Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and parkinson's disease","volume":"127","author":"Samoylenko","year":"2010","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0640","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/sj.bjp.0703294","article-title":"Activation of I(2)-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors","volume":"130","author":"Sanchez-Blazquez","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0645","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/clc.4950250108","article-title":"Sarpogrelate, a specific 5HT2-receptor antagonist, improves the coronary microcirculation in coronary artery disease","volume":"25","author":"Satomura","year":"2002","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.pnpbp.2012.06.001_bb0650","first-page":"49","article-title":"Molecular neuroanatomy of MAO-A and MAO-B","volume":"32","author":"Saura Marti","year":"1990","journal-title":"J Neural Transm Suppl"},{"issue":"5","key":"10.1016\/j.pnpbp.2012.06.001_bb0655","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/FTD.0b013e3181f2b729","article-title":"Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration","volume":"32","author":"Scheidweiler","year":"2010","journal-title":"Ther Drug Monit"},{"issue":"4","key":"10.1016\/j.pnpbp.2012.06.001_bb0660","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.pnpbp.2005.11.035","article-title":"Drugs on the web; the Psychonaut 2002 EU project","volume":"30","author":"Schifano","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0665","first-page":"188","article-title":"Subjective theories about (self-)treatment with ayahuasca","volume":"21","author":"Schmid","year":"2010","journal-title":"AOC"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2012.06.001_bb0670","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.forsciint.2010.06.030","article-title":"\u201cLegal highs\u201d on the net-evaluation of UK-based websites, products and product information","volume":"206","author":"Schmidt","year":"2011","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.pnpbp.2012.06.001_bb0880","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1749-6632.2009.05148.x","article-title":"Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse","volume":"1187","author":"Schmitt","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0680","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0091-3057(03)00129-1","article-title":"Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism","volume":"75","author":"Schwarz","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"issue":"24","key":"10.1016\/j.pnpbp.2012.06.001_bb0685","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.1111\/j.1742-4658.2008.06751.x","article-title":"DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine","volume":"275","author":"Seifert","year":"2008","journal-title":"FEBS J"},{"issue":"8","key":"10.1016\/j.pnpbp.2012.06.001_bb0690","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/138920010794233495","article-title":"Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions","volume":"11","author":"Shen","year":"2010","journal-title":"Curr Drug Metab"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0695","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0014-2999(99)00928-0","article-title":"Vasorelaxant effect of harman","volume":"390","author":"Shi","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.06.001_bb0700","series-title":"Tihkal: the continuation","author":"Shulgin","year":"1997"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0705","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.neuroscience.2008.09.034","article-title":"The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4","volume":"157","author":"Sitz","year":"2008","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.pnpbp.2012.06.001_bb0710","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/jat\/29.8.838","article-title":"A fatal intoxication following the ingestion of 5-methoxy-N,N-DImethyltryptamine in an ayahuasca preparation","volume":"29","author":"Sklerov","year":"2005","journal-title":"J Anal Toxicol"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0715","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsat.2004.03.009","article-title":"A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients","volume":"27","author":"Smelson","year":"2004","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0720","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.jcp.0000194624.07611.5e","article-title":"The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report","volume":"26","author":"Smelson","year":"2006","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0725","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0854.2005.00259.x","article-title":"Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism","volume":"6","author":"Sorkina","year":"2005","journal-title":"Traffic"},{"issue":"10","key":"10.1016\/j.pnpbp.2012.06.001_bb0730","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1017\/S1092852900016965","article-title":"Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants","volume":"13","author":"Stahl","year":"2008","journal-title":"CNS Spectr"},{"issue":"18\u201319","key":"10.1016\/j.pnpbp.2012.06.001_bb0735","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0024-3205(99)00453-1","article-title":"Indole derivatives as neuroprotectants","volume":"65","author":"Stolc","year":"1999","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0740","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1471-4159.2004.02397.x","article-title":"Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake","volume":"89","author":"Storch","year":"2004","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.06.001_bb0885","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archpsyc.1994.03950020009001","article-title":"Dose\u2013response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects","volume":"51","author":"Strassman","year":"1994","journal-title":"Arch Gen Psychiatry"},{"issue":"61","key":"10.1016\/j.pnpbp.2012.06.001_bb0890","doi-asserted-by":"crossref","first-page":"pe12","DOI":"10.1126\/scisignal.261pe12","article-title":"When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor","volume":"2","author":"Su","year":"2009","journal-title":"Sci Signal"},{"key":"10.1016\/j.pnpbp.2012.06.001_bb0755","first-page":"78","article-title":"Dimethyltryptamine as a new psychotic agent","volume":"11","author":"Szara","year":"1957","journal-title":"Acta Physiol Hung"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0760","first-page":"22","article-title":"Ayahuasca and cancer: one man's experience","volume":"8","author":"Topping","year":"1998","journal-title":"MAPS Bull"},{"issue":"4","key":"10.1016\/j.pnpbp.2012.06.001_bb0765","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.drugpo.2006.11.001","article-title":"The globalization of ayahuasca: harm reduction or benefit maximization?","volume":"19","author":"Tupper","year":"2008","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0770","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/dmd.111.041210","article-title":"Prediction of CYP2D6 drug interactions from in vitro data: evidence for substrate-dependent inhibition","volume":"40","author":"Vandenbrink","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.pnpbp.2012.06.001_bb0775","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1523\/JNEUROSCI.4901-04.2006","article-title":"Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool","volume":"26","author":"Venton","year":"2006","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.pnpbp.2012.06.001_bb0780","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/sj.npp.1300987","article-title":"Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine","volume":"31","author":"Villegier","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2012.06.001_bb0785","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/386827a0","article-title":"Relationship between subjective effects of cocaine and dopamine transporter occupancy","volume":"386","author":"Volkow","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0790","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jep.2010.02.013","article-title":"Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease","volume":"128","author":"Wang","year":"2010","journal-title":"J Ethnopharmacol"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2012.06.001_bb0795","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainres.2004.03.008","article-title":"Cell type- and brain structure-specific patterns of distribution of minibrain kinase in human brain","volume":"1010","author":"Wegiel","year":"2004","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.06.001_bb0800","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.pneurobio.2010.06.008","article-title":"Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity","volume":"92","author":"Weinreb","year":"2010","journal-title":"Prog Neurobiol"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.06.001_bb0805","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/jpet.102.047050","article-title":"Contribution of individual cytochrome P450 isozymes to the o-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine","volume":"305","author":"Yu","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2012.06.001_bb0810","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuropharm.2004.07.010","article-title":"Rapid regulation of the dopamine transporter: role in stimulant addiction?","volume":"47","author":"Zahniser","year":"2004","journal-title":"Neuropharmacology"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2012.06.001_bb0815","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00213-010-1996-3","article-title":"Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats","volume":"213","author":"Zayara","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.pnpbp.2012.06.001_bb0820","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/ptr.3458","article-title":"Inhibition of human cytochrome P450 enzymes 3A4 and 2D6 by beta-carboline alkaloids, harmine derivatives","volume":"25","author":"Zhao","year":"2011","journal-title":"Phytother Res"},{"issue":"11","key":"10.1016\/j.pnpbp.2012.06.001_bb0825","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2165\/11318030-000000000-00000","article-title":"Polymorphism of human cytochrome P450 2D6 and its clinical significance: part I","volume":"48","author":"Zhou","year":"2009","journal-title":"Clin Pharmacokinet"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584612001364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584612001364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T06:02:42Z","timestamp":1714024962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584612001364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":163,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0278584612001364"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2012.06.001","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}